Sidley Advised KKR on Its Investment in Biosynth Carbosynth

Nov 23, 2021

Posted by Sidley Austin

Sidley advised KKR on its majority acquisition of Biosynth Carbosynth, a life sciences reagents and custom synthesis and manufacturing services company headquartered in Switzerland, with further operations in the UK, the U.S., Slovakia, and China. Biosynth Carbosynth supplies products to players across the pharmaceutical, life sciences, food, agrochemical, cosmetic and diagnostic sectors, and manufactures and sources a range of chemical and biochemical products. Continue reading 

See all Member News